Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Anxiety and depression are common in patients with severe chronic obstructive pulmonary
disease (COPD). Frequently exacerbation's of breathlessness are associated with panic/fear
and indeed this may be the main cause for the for hospital admission. Patients prone to a
tendency to experience and communicate somatic distress in response to psychosocial stress
and to seek medical help for it are top of the "frequent flyer" league, costing the health
care economy dearly. This is a particular problem in Hull with the high levels of smoking and
urban deprivation combining to place the city at the bottom of the Department of Health COPD
league tables.
Our hypothesis is that an effective treatment for anxiety will reduce the number of episodes
of hospital admission by reducing the panic/fear element of mild COPD exacerbation's thus
allowing the patient time to access the existing community based support services.
Phase:
Phase 3
Details
Lead Sponsor:
Hull and East Yorkshire Hospitals NHS Trust Hull University Teaching Hospitals NHS Trust